PBS Biotech

PBS Biotech

PBS Biotech is produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry.

Launch date
Employees
Market cap
-
Enterprise valuation
$88—132m (Dealroom.co estimates Jan 2023.)
Camarillo California (HQ)
  • Edit
DateInvestorsAmountRound

$10.0m

Late VC
*

$22.0m

Late VC
Total Funding$32.0m

Recent News about PBS Biotech

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.